首页 > 最新文献

NEW ZEALAND MEDICAL JOURNAL最新文献

英文 中文
Promoting digital inclusion for enhanced resident wellbeing: an examination of aged residential care facility websites. 促进数字共融,提升居民福祉:对养老机构网站的研究。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-23 DOI: 10.26635/6965.6511
Wendy Wrapson, Chiara Gasteiger

Aim: Digital inclusion has a positive impact on health and wellbeing through fostering connectivity and access to information. In Aotearoa New Zealand, 4% of older adults live in aged residential care (ARC) facilities and are vulnerable to social isolation. This study explored whether ARC facilities provide opportunities to socially connect online and whether the COVID-19 pandemic affected the provision of these opportunities.

Method: Information on technology and internet provision from 558 ARC facilities was extracted from facilities' own or related websites in 2019 and 2021. ARC facilities were categorised according to whether they provided digital devices, internet access and internet-based leisure activities, or made no reference to technology.

Results: In 2019, 392 (70%) of 558 ARC facilities publicised availability of internet-based technologies for residents; however, only 46 (8%) mentioned providing access to computer devices. In 2021 (during the pandemic), there was a small increase to 421 (76%) and 54 (10%) of facilities respectively. Facilities mentioning internet-based leisure activities were 63 (11%) in 2019 and 55 (10%) in 2021. Those not referring to technology had reduced from 166 (30%) in 2019 to 137 (24%) in 2021.

Conclusion: Few ARC facilities enabled residents to fully access the digital world, even after periods of isolation due to COVID-19. Aged care providers could be more proactive by providing internet access and digital learning opportunities.

目的:数字包容性通过促进连接和信息获取,对健康和福祉产生积极影响。在新西兰奥特亚罗瓦,4% 的老年人生活在老年寄宿护理机构(ARC)中,容易受到社会孤立。本研究探讨了老年寄宿护理机构是否提供了在线社交联系的机会,以及 COVID-19 大流行是否影响了这些机会的提供:方法:研究人员从 558 家 ARC 机构的自有网站或相关网站上提取了 2019 年和 2021 年的技术和网络提供信息。ARC 设施根据是否提供数字设备、互联网接入和基于互联网的休闲活动,或未提及技术进行分类:2019年,558家ARC设施中有392家(70%)宣传可为居民提供基于互联网的技术;但只有46家(8%)提到可提供电脑设备。到了 2021 年(大流行期间),提及为居民提供互联网技术的设施分别小幅增加到 421 家(76%)和 54 家(10%)。提及互联网休闲活动的设施在 2019 年为 63 个(11%),2021 年为 55 个(10%)。未提及科技的设施从 2019 年的 166 个(30%)减少到 2021 年的 137 个(24%):结论:即使在因 COVID-19 而被隔离一段时间后,也很少有 ARC 设施能让居民充分访问数字世界。老年护理机构可以通过提供互联网接入和数字化学习机会来更加积极主动地开展工作。
{"title":"Promoting digital inclusion for enhanced resident wellbeing: an examination of aged residential care facility websites.","authors":"Wendy Wrapson, Chiara Gasteiger","doi":"10.26635/6965.6511","DOIUrl":"https://doi.org/10.26635/6965.6511","url":null,"abstract":"<p><strong>Aim: </strong>Digital inclusion has a positive impact on health and wellbeing through fostering connectivity and access to information. In Aotearoa New Zealand, 4% of older adults live in aged residential care (ARC) facilities and are vulnerable to social isolation. This study explored whether ARC facilities provide opportunities to socially connect online and whether the COVID-19 pandemic affected the provision of these opportunities.</p><p><strong>Method: </strong>Information on technology and internet provision from 558 ARC facilities was extracted from facilities' own or related websites in 2019 and 2021. ARC facilities were categorised according to whether they provided digital devices, internet access and internet-based leisure activities, or made no reference to technology.</p><p><strong>Results: </strong>In 2019, 392 (70%) of 558 ARC facilities publicised availability of internet-based technologies for residents; however, only 46 (8%) mentioned providing access to computer devices. In 2021 (during the pandemic), there was a small increase to 421 (76%) and 54 (10%) of facilities respectively. Facilities mentioning internet-based leisure activities were 63 (11%) in 2019 and 55 (10%) in 2021. Those not referring to technology had reduced from 166 (30%) in 2019 to 137 (24%) in 2021.</p><p><strong>Conclusion: </strong>Few ARC facilities enabled residents to fully access the digital world, even after periods of isolation due to COVID-19. Aged care providers could be more proactive by providing internet access and digital learning opportunities.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1601","pages":"28-35"},"PeriodicalIF":1.2,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and feasibility of same-day discharge for per-oral endoscopic myotomy. 经口内窥镜肌切开术当天出院的安全性和可行性。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-23 DOI: 10.26635/6965.6583
Jun Young Kim, Michael Chieng, Rees Cameron, Frank Weilert

Aims: Per-oral endoscopic myotomy (POEM) is a recognised treatment for achalasia, with the accepted approach involving admission for imaging and dietary progression. However, recent publications suggest same-day discharge (SDD) may be possible, which could be time and cost-saving. We sought to investigate the safety of SDD following POEM.

Methods: Fifty consecutive POEMs at two referral centres in New Zealand were performed between 2020-2023. All patients were planned for early dietary introduction and were eligible for SDD if symptoms were managed. Analgesia was available in recovery and supplied at discharge. Imaging and endoscopy were performed only if there were clinical concerns. Rates of discharge clearance, discharge, complications and re-admission were analysed.

Results: All 50 POEMs were technically successful. A total of 41/50 (82%) received clearance for SDD. Additionally, 35/50 (70%) achieved discharge and 6/50 (12%) were observed overnight for social reasons, including lack of transport to the referring domicile. Of the patients not cleared for SDD, 7/9 (78%) were discharged within 24 hours, and the others after 48 and 72 hours. Procedural complications were recorded in three patients (6%), with one requiring endoscopic assessment and clipping. There were two re-admissions (4%), both lt;24-hour hospital stays, and managed medically.

Conclusions: The majority of patients achieved same-day discharge clearance (82%) and 96% required less than 24 hours hospital stay. Complication and re-admission rates were low overall. We have demonstrated that POEM can be an SDD procedure facilitated by early dietary introduction and liberal analgesia, without the need for routine imaging or endoscopy.

目的:经口内窥镜肌切开术(POEM)是公认的治疗贲门失弛缓症的方法,公认的方法包括入院进行影像学检查和饮食治疗。然而,最近的出版物表明,当天出院(SDD)是可能的,这可以节省时间和费用。我们试图研究 POEM 后 SDD 的安全性:2020-2023 年间,新西兰两家转诊中心连续进行了 50 例 POEM。所有患者均计划进行早期饮食导入,如果症状得到控制,则有资格进行 SDD。恢复期可使用镇痛剂,出院时也可使用。只有在有临床问题时才进行成像和内窥镜检查。对出院清除率、出院率、并发症和再次入院率进行了分析:所有 50 例 POEM 在技术上都很成功。共有 41/50 例(82%)获得了 SDD 许可。此外,35/50(70%)的患者获得出院,6/50(12%)的患者因社会原因(包括缺乏前往转诊地的交通工具)而需要留院观察一晚。在未获准进行 SDD 的患者中,7/9(78%)在 24 小时内出院,其他患者分别在 48 小时和 72 小时后出院。三名患者(6%)出现了手术并发症,其中一名患者需要进行内窥镜评估和剪切。有两名患者(4%)再次入院,均住院24小时,并接受了药物治疗:大多数患者都能在当天出院(82%),96%的患者住院时间少于24小时。并发症和再次入院率总体较低。我们已经证明,POEM 可以是一种 SDD 手术,通过早期饮食导入和宽松的镇痛,无需进行常规成像或内窥镜检查。
{"title":"Safety and feasibility of same-day discharge for per-oral endoscopic myotomy.","authors":"Jun Young Kim, Michael Chieng, Rees Cameron, Frank Weilert","doi":"10.26635/6965.6583","DOIUrl":"https://doi.org/10.26635/6965.6583","url":null,"abstract":"<p><strong>Aims: </strong>Per-oral endoscopic myotomy (POEM) is a recognised treatment for achalasia, with the accepted approach involving admission for imaging and dietary progression. However, recent publications suggest same-day discharge (SDD) may be possible, which could be time and cost-saving. We sought to investigate the safety of SDD following POEM.</p><p><strong>Methods: </strong>Fifty consecutive POEMs at two referral centres in New Zealand were performed between 2020-2023. All patients were planned for early dietary introduction and were eligible for SDD if symptoms were managed. Analgesia was available in recovery and supplied at discharge. Imaging and endoscopy were performed only if there were clinical concerns. Rates of discharge clearance, discharge, complications and re-admission were analysed.</p><p><strong>Results: </strong>All 50 POEMs were technically successful. A total of 41/50 (82%) received clearance for SDD. Additionally, 35/50 (70%) achieved discharge and 6/50 (12%) were observed overnight for social reasons, including lack of transport to the referring domicile. Of the patients not cleared for SDD, 7/9 (78%) were discharged within 24 hours, and the others after 48 and 72 hours. Procedural complications were recorded in three patients (6%), with one requiring endoscopic assessment and clipping. There were two re-admissions (4%), both lt;24-hour hospital stays, and managed medically.</p><p><strong>Conclusions: </strong>The majority of patients achieved same-day discharge clearance (82%) and 96% required less than 24 hours hospital stay. Complication and re-admission rates were low overall. We have demonstrated that POEM can be an SDD procedure facilitated by early dietary introduction and liberal analgesia, without the need for routine imaging or endoscopy.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1601","pages":"48-54"},"PeriodicalIF":1.2,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Twenty-year review of the bariatric programme at Te Whatu Ora Waitematā. Te Whatu Ora Waitematā减肥计划二十年回顾。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-23 DOI: 10.26635/6965.6472
Megan Grinlinton, Mavis Orizu, Michael Booth

Aims: Obesity is a significant health issue. Te Whatu Ora Waitematā serves a population of 650,000 patients across the North Shore, Waitākere and Rodney areas. The Waitematā bariatric service at North Shore Hospital was introduced in October 2001. The aim of this study was to review the development and impact of the service over the last 20 years, and identify whether equivalent bariatric services could viably be introduced into other hospitals in Aotearoa New Zealand.

Methods: A retrospective audit was conducted of the 20-year results of the Waitematā bariatric surgical service to identify the impact of technology, teaching and research on service provision.

Results: Since its inception, the Waitematā bariatric service has launched minimally invasive surgery, multiple operative options and an enhanced recovery after surgery (ERAS) protocol. Approximately 100 cases are performed per year. Of these, 3.4% of patients require admission to the intensive care unit/high dependency unit (ICU/HDU), with an average length of stay (LOS) of 0.66 days. The 1-year mortality rate is 0.39%. Eleven surgical fellows have undergone post-fellowship training with the service, which is a recognised training unit for the post-fellowship AANZGOSA/ANZMOSS programme.

Conclusions: Bariatric surgery can be performed safely and has good long-term outcomes. The Waitematā bariatric service is dedicated to providing excellent care within the resource constraints of a public healthcare system. The high number of procedures, low requirement for ICU/HDU and low mortality rate suggest that bariatric surgery could be safely performed within a public setting in secondary and regional hospitals across the country.

目的:肥胖症是一个严重的健康问题。Te Whatu Ora Waitematā 为北岸、怀塔凯尔和罗德尼地区的 65 万病人提供服务。北岸医院于 2001 年 10 月推出了 Waitematā 减肥服务。这项研究的目的是回顾过去20年中这项服务的发展和影响,并确定是否可以在新西兰奥特亚罗瓦的其他医院中引入类似的减肥服务:方法:对Waitematā减肥手术服务20年来的成果进行回顾性审核,以确定技术、教学和研究对服务提供的影响:自成立以来,Waitematā 减肥服务推出了微创手术、多种手术方案和增强型术后恢复(ERAS)方案。每年大约进行 100 例手术。其中,3.4% 的患者需要入住重症监护室/高依赖性病房(ICU/HDU),平均住院时间(LOS)为 0.66 天。1 年死亡率为 0.39%。11名外科研究员在该服务机构接受了研究员后培训,该服务机构是AANZGOSA/ANZMOSS研究员后计划的认可培训单位:结论:减肥手术可以安全地进行,并且具有良好的长期疗效。怀特马减肥服务致力于在公共医疗系统资源有限的情况下提供优质护理。手术数量多、对重症监护室/重症加护病房的需求低、死亡率低,这表明减肥手术可以在全国各地的二级医院和地区医院的公共环境中安全进行。
{"title":"Twenty-year review of the bariatric programme at Te Whatu Ora Waitematā.","authors":"Megan Grinlinton, Mavis Orizu, Michael Booth","doi":"10.26635/6965.6472","DOIUrl":"https://doi.org/10.26635/6965.6472","url":null,"abstract":"<p><strong>Aims: </strong>Obesity is a significant health issue. Te Whatu Ora Waitematā serves a population of 650,000 patients across the North Shore, Waitākere and Rodney areas. The Waitematā bariatric service at North Shore Hospital was introduced in October 2001. The aim of this study was to review the development and impact of the service over the last 20 years, and identify whether equivalent bariatric services could viably be introduced into other hospitals in Aotearoa New Zealand.</p><p><strong>Methods: </strong>A retrospective audit was conducted of the 20-year results of the Waitematā bariatric surgical service to identify the impact of technology, teaching and research on service provision.</p><p><strong>Results: </strong>Since its inception, the Waitematā bariatric service has launched minimally invasive surgery, multiple operative options and an enhanced recovery after surgery (ERAS) protocol. Approximately 100 cases are performed per year. Of these, 3.4% of patients require admission to the intensive care unit/high dependency unit (ICU/HDU), with an average length of stay (LOS) of 0.66 days. The 1-year mortality rate is 0.39%. Eleven surgical fellows have undergone post-fellowship training with the service, which is a recognised training unit for the post-fellowship AANZGOSA/ANZMOSS programme.</p><p><strong>Conclusions: </strong>Bariatric surgery can be performed safely and has good long-term outcomes. The Waitematā bariatric service is dedicated to providing excellent care within the resource constraints of a public healthcare system. The high number of procedures, low requirement for ICU/HDU and low mortality rate suggest that bariatric surgery could be safely performed within a public setting in secondary and regional hospitals across the country.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1601","pages":"17-27"},"PeriodicalIF":1.2,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asian health in Aotearoa New Zealand: highlights and actionable insights. 新西兰奥特亚罗亚的亚裔健康:亮点和可行见解。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-23 DOI: 10.26635/6965.6705
Sherly Parackal, Eleanor Holroyd
{"title":"Asian health in Aotearoa New Zealand: highlights and actionable insights.","authors":"Sherly Parackal, Eleanor Holroyd","doi":"10.26635/6965.6705","DOIUrl":"10.26635/6965.6705","url":null,"abstract":"","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1601","pages":"14-16"},"PeriodicalIF":1.2,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence to national Lynch syndrome testing guidelines for colorectal cancer in an Aotearoa New Zealand hospital-based population. 新西兰奥特亚罗瓦医院人群中遵守国家林奇综合征结直肠癌检测指南的情况。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-02 DOI: 10.26635/6965.6551
Nejo Joseph, Matthew McGuinness, Cavaghn H Prosser, Georgina Trifinovich, William Xu, Christopher Harmston

Aim: Lynch syndrome (LS) is estimated to affect 1-3.9% of patients with colorectal cancer (CRC). Testing for LS is important in determining management and establishing surveillance for "Lynch families". Previous studies have identified poor rates of testing for LS in CRC patients. This study aimed to describe adherence to guidelines for testing of newly diagnosed CRC for LS.

Methods: A single institution cohort study of patients over 18 years with colorectal adenocarcinoma from 2018-2022 in Te Tai Tokerau, Aotearoa New Zealand was conducted. Rates of baseline immunohistochemistry (IHC) testing for mismatch repair (MMR) deficiency, further testing for MLH1-deficient cases and rates of germline mutational analysis were audited to determine adherence to national guidelines. The rate of LS in newly diagnosed CRC was estimated.

Results: Six hundred and sixty patients were eligible for universal testing for LS, of which 84% (n=553) completed initial IHC testing. MMR deficiency was reported in 20% (n=114) cases. Eighty-nine percent (n=101) was attributable to MLH1 deficiency, of which 99% (n=100) were appropriately tested for BRAF-V600E mutation. Sixty-four percent (4/11) patients indicated for hypermethylation testing were appropriately tested. Seventeen patients had an indication for germline mutational analysis, of which only 29% (n=5) were tested. The estimated incidence of LS in newly diagnosed CRC was 0.7-3.8%.

Conclusion: Compliance with initial IHC testing was good. However, there is a need to improve rates of confirmation genetic testing. The incidence of confirmed LS in this study is 0.7%, however this may be as high as 3.9%.

目的:据估计,1-3.9% 的结直肠癌 (CRC) 患者患有林奇综合征 (LS)。林奇综合征检测对于确定治疗方案和建立 "林奇家族 "监测非常重要。以往的研究发现,CRC 患者的 LS 检测率很低。本研究旨在描述新诊断 CRC LS 检测指南的遵守情况:该研究对新西兰奥特亚罗瓦 Te Tai Tokerau 地区 2018-2022 年间 18 岁以上结直肠腺癌患者进行了单机构队列研究。对错配修复(MMR)缺陷的基线免疫组化(IHC)检测率、MLH1缺陷病例的进一步检测率和种系突变分析率进行了审核,以确定是否符合国家指南。对新诊断出的 CRC 的 LS 率进行了估算:有660名患者符合LS普遍检测的条件,其中84%(n=553)的患者完成了初步IHC检测。20%的病例(n=114)报告缺乏 MMR。89%的病例(n=101)可归因于MLH1缺乏,其中99%的病例(n=100)进行了适当的BRAF-V600E突变检测。64%(4/11)的患者有进行高甲基化检测的指征,并进行了适当的检测。17名患者有进行种系突变分析的指征,其中只有29%(n=5)的患者接受了检测。在新诊断的 CRC 中,LS 的估计发生率为 0.7%-3.8%:结论:初次 IHC 检测的依从性良好。然而,需要提高基因检测的确认率。本研究中确诊 LS 的发生率为 0.7%,但可能高达 3.9%。
{"title":"Adherence to national Lynch syndrome testing guidelines for colorectal cancer in an Aotearoa New Zealand hospital-based population.","authors":"Nejo Joseph, Matthew McGuinness, Cavaghn H Prosser, Georgina Trifinovich, William Xu, Christopher Harmston","doi":"10.26635/6965.6551","DOIUrl":"10.26635/6965.6551","url":null,"abstract":"<p><strong>Aim: </strong>Lynch syndrome (LS) is estimated to affect 1-3.9% of patients with colorectal cancer (CRC). Testing for LS is important in determining management and establishing surveillance for \"Lynch families\". Previous studies have identified poor rates of testing for LS in CRC patients. This study aimed to describe adherence to guidelines for testing of newly diagnosed CRC for LS.</p><p><strong>Methods: </strong>A single institution cohort study of patients over 18 years with colorectal adenocarcinoma from 2018-2022 in Te Tai Tokerau, Aotearoa New Zealand was conducted. Rates of baseline immunohistochemistry (IHC) testing for mismatch repair (MMR) deficiency, further testing for MLH1-deficient cases and rates of germline mutational analysis were audited to determine adherence to national guidelines. The rate of LS in newly diagnosed CRC was estimated.</p><p><strong>Results: </strong>Six hundred and sixty patients were eligible for universal testing for LS, of which 84% (n=553) completed initial IHC testing. MMR deficiency was reported in 20% (n=114) cases. Eighty-nine percent (n=101) was attributable to MLH1 deficiency, of which 99% (n=100) were appropriately tested for BRAF-V600E mutation. Sixty-four percent (4/11) patients indicated for hypermethylation testing were appropriately tested. Seventeen patients had an indication for germline mutational analysis, of which only 29% (n=5) were tested. The estimated incidence of LS in newly diagnosed CRC was 0.7-3.8%.</p><p><strong>Conclusion: </strong>Compliance with initial IHC testing was good. However, there is a need to improve rates of confirmation genetic testing. The incidence of confirmed LS in this study is 0.7%, however this may be as high as 3.9%.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1600","pages":"31-39"},"PeriodicalIF":1.2,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes treatment satisfaction among a multi-ethnic Aotearoa New Zealand population with uncontrolled type 2 diabetes mellitus. 新西兰奥特亚罗瓦多民族未受控制的 2 型糖尿病患者对糖尿病治疗的满意度。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-02 DOI: 10.26635/6965.6341
Ry Yves Tweedie-Cullen, Yannan Jiang, Rebecca Brandon, Audrey Tay, Ryan Yeu, Kate Smallman, Glenn Doherty, Ofa Dewes, Rebekah Doran, Penny Clark, Norma Nehren, Jennie Harré Hindmarsh, Frances King, Tony R Merriman, Brandon Orr-Walker, Ryan Paul, Rinki Murphy, Allan Moffitt

Aims: To assess whether diabetes treatment satisfaction differs by ethnicity among participants with insufficient glycaemic control of type 2 diabetes mellitus in a clinical trial involving additional oral diabetes medications. Patient satisfaction is used as an indicator of healthcare quality. However, data on patients' diabetes treatment satisfaction in the context of insufficient glycaemic control is limited.

Methods: Individuals with type 2 diabetes and an HbA1c of 58-110mmol/mol (7.5-12.5%) were recruited across Aotearoa New Zealand to participate in an 8-month randomised crossover study of vildagliptin and pioglitazone as add-on therapy to metformin and/or sulfonylurea. Participants completed the Diabetes Treatment Satisfaction Questionnaire (DTSQ) at baseline pre-randomisation. Treatment satisfaction scores were compared between ethnic groups and other characteristics using the analysis of variance and linear regression. Perceived hyper- and hypoglycaemia were summarised separately.

Results: Between February 2019 and March 2020, 346 participants (41% women, 32% Pacific peoples, 23% Māori, 26% European) completed the DTSQ. Mean (SD) age was 57.5 (10.9) years, diabetes duration was 9 (6.3) years and HbA1c was 75 (12)mmol/mol (9.0[3.2]%). At study entry, 40% were receiving monotherapy for diabetes. Treatment satisfaction was rated highly, with a score of 29(6) (interquartile range 25-33). Pacific peoples and older people reported greater treatment satisfaction than other groups (p<0.001).

Conclusions: Diabetes treatment satisfaction was high, particularly among Pacific peoples, despite suboptimal glycaemic control and insufficient glucose-lowering therapy.

目的:在一项涉及额外口服糖尿病药物的临床试验中,评估血糖控制不佳的 2 型糖尿病参与者的糖尿病治疗满意度是否因种族而异。患者满意度被用作衡量医疗质量的指标。然而,有关患者在血糖控制不足的情况下对糖尿病治疗满意度的数据却很有限:方法:在新西兰奥特亚罗亚地区招募 HbA1c 为 58-110mmol/mol (7.5-12.5%) 的 2 型糖尿病患者,参加为期 8 个月的随机交叉研究,将维达列汀和吡格列酮作为二甲双胍和/或磺脲类药物的附加疗法。参与者在随机前的基线填写了糖尿病治疗满意度问卷(DTSQ)。采用方差分析和线性回归法比较了不同种族群体和其他特征之间的治疗满意度得分。分别总结了感知到的高血糖和低血糖情况:2019年2月至2020年3月期间,346名参与者(41%为女性,32%为太平洋岛屿族裔,23%为毛利人,26%为欧洲人)完成了DTSQ。平均(标清)年龄为 57.5 (10.9) 岁,糖尿病病程为 9 (6.3) 年,HbA1c 为 75 (12)mmol/mol (9.0[3.2]%)。研究开始时,40%的糖尿病患者正在接受单一疗法。患者对治疗的满意度很高,得分为 29(6)(四分位数间距为 25-33)。太平洋岛民和老年人的治疗满意度高于其他群体(P结论:尽管血糖控制不理想且降糖治疗不足,但糖尿病治疗满意度很高,尤其是太平洋岛屿族裔。
{"title":"Diabetes treatment satisfaction among a multi-ethnic Aotearoa New Zealand population with uncontrolled type 2 diabetes mellitus.","authors":"Ry Yves Tweedie-Cullen, Yannan Jiang, Rebecca Brandon, Audrey Tay, Ryan Yeu, Kate Smallman, Glenn Doherty, Ofa Dewes, Rebekah Doran, Penny Clark, Norma Nehren, Jennie Harré Hindmarsh, Frances King, Tony R Merriman, Brandon Orr-Walker, Ryan Paul, Rinki Murphy, Allan Moffitt","doi":"10.26635/6965.6341","DOIUrl":"10.26635/6965.6341","url":null,"abstract":"<p><strong>Aims: </strong>To assess whether diabetes treatment satisfaction differs by ethnicity among participants with insufficient glycaemic control of type 2 diabetes mellitus in a clinical trial involving additional oral diabetes medications. Patient satisfaction is used as an indicator of healthcare quality. However, data on patients' diabetes treatment satisfaction in the context of insufficient glycaemic control is limited.</p><p><strong>Methods: </strong>Individuals with type 2 diabetes and an HbA1c of 58-110mmol/mol (7.5-12.5%) were recruited across Aotearoa New Zealand to participate in an 8-month randomised crossover study of vildagliptin and pioglitazone as add-on therapy to metformin and/or sulfonylurea. Participants completed the Diabetes Treatment Satisfaction Questionnaire (DTSQ) at baseline pre-randomisation. Treatment satisfaction scores were compared between ethnic groups and other characteristics using the analysis of variance and linear regression. Perceived hyper- and hypoglycaemia were summarised separately.</p><p><strong>Results: </strong>Between February 2019 and March 2020, 346 participants (41% women, 32% Pacific peoples, 23% Māori, 26% European) completed the DTSQ. Mean (SD) age was 57.5 (10.9) years, diabetes duration was 9 (6.3) years and HbA1c was 75 (12)mmol/mol (9.0[3.2]%). At study entry, 40% were receiving monotherapy for diabetes. Treatment satisfaction was rated highly, with a score of 29(6) (interquartile range 25-33). Pacific peoples and older people reported greater treatment satisfaction than other groups (p<0.001).</p><p><strong>Conclusions: </strong>Diabetes treatment satisfaction was high, particularly among Pacific peoples, despite suboptimal glycaemic control and insufficient glucose-lowering therapy.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1600","pages":"66-75"},"PeriodicalIF":1.2,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intentional physical self-injury in Auckland: patterns, associations and clinical implications in a single-centre cross-sectional study. 奥克兰的故意肢体自残:单中心横断面研究的模式、关联和临床影响。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-02 DOI: 10.26635/6965.6344
Divyansh Panesar, Ian Civil

Introduction: Intentional physical self-injury (IPSI) is a pressing health challenge and there is little awareness of injury patterns, management and outcomes. This study examines IPSI's epidemiological and clinical aspects in one major Auckland hospital, highlighting demography, injury patterns and implications for clinical practice and prevention.

Methods: Using Auckland City Hospital Trauma Registry data, a retrospective, descriptive study was conducted covering adult patients admitted from January 2015 to December 2019. It assessed demographic characteristics, injury patterns and outcomes, using Mann-Whitney U tests, Fisher's exact tests and Chi-squared tests.

Results: Among 137 IPSI admissions, 92 (67%) required surgery, and 24% experienced post-operative complications. Major trauma was identified in 39 (28.5%) admissions. Discharge destinations varied, with only 64 (47%) patients returning home unassisted. Injury severity did not significantly vary across sex, age or injury event location. Major injuries often resulted from falls (19 of 39) and minor injuries from lacerations/stabs (73 of 98).

Conclusions: IPSI represents a significant challenge to Auckland health services, with a notable burden of care. The study highlights the need for targeted interventions to reduce the incidence of IPSI and improve outcomes. It underscores the importance of multidisciplinary approaches to care, integrating surgical, mental health and rehabilitative services.

导言:蓄意肢体自伤(IPSI)是一项紧迫的健康挑战,但人们对其伤害模式、管理和结果却知之甚少。本研究探讨了 IPSI 在奥克兰一家大型医院的流行病学和临床方面的问题,重点关注人口统计、伤害模式以及对临床实践和预防的影响:利用奥克兰市立医院创伤登记处的数据,对 2015 年 1 月至 2019 年 12 月期间入院的成年患者进行了一项回顾性描述研究。研究采用曼-惠特尼U检验、费雪精确检验和卡方检验对人口统计学特征、损伤模式和结果进行了评估:在收治的137名IPSI患者中,92人(67%)需要手术治疗,24%出现术后并发症。有 39 例(28.5%)入院患者出现严重外伤。患者出院后的去向各不相同,只有 64 名(47%)患者能在无人协助的情况下回家。不同性别、年龄或受伤地点的受伤严重程度没有明显差异。重伤通常由跌倒造成(39 例中有 19 例),轻伤由撕裂伤/刺伤造成(98 例中有 73 例):结论:IPSI 是奥克兰医疗服务面临的一项重大挑战,给医疗服务带来了沉重负担。这项研究强调了有必要采取有针对性的干预措施,以减少 IPSI 的发生率并改善治疗效果。它强调了多学科护理方法的重要性,整合了外科、心理健康和康复服务。
{"title":"Intentional physical self-injury in Auckland: patterns, associations and clinical implications in a single-centre cross-sectional study.","authors":"Divyansh Panesar, Ian Civil","doi":"10.26635/6965.6344","DOIUrl":"https://doi.org/10.26635/6965.6344","url":null,"abstract":"<p><strong>Introduction: </strong>Intentional physical self-injury (IPSI) is a pressing health challenge and there is little awareness of injury patterns, management and outcomes. This study examines IPSI's epidemiological and clinical aspects in one major Auckland hospital, highlighting demography, injury patterns and implications for clinical practice and prevention.</p><p><strong>Methods: </strong>Using Auckland City Hospital Trauma Registry data, a retrospective, descriptive study was conducted covering adult patients admitted from January 2015 to December 2019. It assessed demographic characteristics, injury patterns and outcomes, using Mann-Whitney U tests, Fisher's exact tests and Chi-squared tests.</p><p><strong>Results: </strong>Among 137 IPSI admissions, 92 (67%) required surgery, and 24% experienced post-operative complications. Major trauma was identified in 39 (28.5%) admissions. Discharge destinations varied, with only 64 (47%) patients returning home unassisted. Injury severity did not significantly vary across sex, age or injury event location. Major injuries often resulted from falls (19 of 39) and minor injuries from lacerations/stabs (73 of 98).</p><p><strong>Conclusions: </strong>IPSI represents a significant challenge to Auckland health services, with a notable burden of care. The study highlights the need for targeted interventions to reduce the incidence of IPSI and improve outcomes. It underscores the importance of multidisciplinary approaches to care, integrating surgical, mental health and rehabilitative services.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1600","pages":"40-51"},"PeriodicalIF":1.2,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time to start disease modifying drugs for adults with seropositive rheumatoid arthritis: results of the first year of the national New Zealand Rheumatology Association (NZRA) audit. 血清反应呈阳性的成人类风湿关节炎患者开始服用改变病情药物的时间:新西兰全国风湿病学协会(NZRA)第一年的审计结果。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-02 DOI: 10.26635/6965.6414
William J Taylor, Nicola Dalbeth, Tracey Kain, Douglas White, Rebecca Grainger, Vicky Quincey

Aim: This audit describes variation in the time from referral to starting disease modifying drug (DMARD) for people with newly diagnosed seropositive rheumatoid arthritis (RA), how frequently this was within the recommended 6 weeks and whether regional, service-level or patient-level factors were associated with this variation.

Method: Rheumatologists submitted data on new patients with a new diagnosis of rheumatoid factor and/or cyclic-citrullinated peptide antibody positive RA. The association between visit funding, ethnicity, socio-economic deprivation, rurality, local specialist staffing levels and the time to DMARD treatment was assessed using Cox proportional-hazard models.

Results: Data were collected on 355 patients over 12 months. Overall, 64.8% of patients commenced DMARD treatment within 6 weeks of referral and this was associated with rheumatologist FTE per 100,000 population (adjusted HR 2.47, 95%CI 1.27-4.81; p=0.008) and the rurality (Geographic Classification of Health [GCH]) of the patient (for R2 compared to U1 adjusted HR 0.20, 95%CI 0.09-0.43; p<0.001). There was no association between time to DMARD and ethnicity or socio-economic deprivation.

Conclusion: There was significant variation in time to DMARD treatment, mainly related to variation in rheumatologist staffing levels and patient rurality. Rheumatologist staffing levels of 1.0 FTE/100,000 population was associated with 80% of patients meeting the recommended 6-week time to DMARD treatment.

目的:本审计报告描述了新诊断为血清反应阳性类风湿关节炎(RA)患者从转诊到开始使用改良疾病药物(DMARD)的时间差异、在建议的6周内开始用药的频率,以及地区、服务层面或患者层面的因素是否与这一差异有关:风湿免疫科医生提交了新诊断为类风湿因子和/或环瓜氨酸肽抗体阳性类风湿关节炎患者的数据。采用Cox比例危险模型评估了就诊资金、种族、社会经济贫困程度、乡村地区、当地专科医生配备水平和DMARD治疗时间之间的关联:在12个月内收集了355名患者的数据。总体而言,64.8%的患者在转诊后6周内开始接受DMARD治疗,这与每10万人口风湿免疫科全职医生数量(调整后HR为2.47,95%CI为1.27-4.81;p=0.008)和患者的偏远地区(健康地理分类[GCH])有关(R2与U1相比,调整后HR为0.20,95%CI为0.09-0.43;p):DMARD治疗时间存在明显差异,这主要与风湿免疫科医生的人员配备水平和患者所在地区有关。风湿免疫科医生的人员配备水平为 1.0 FTE/100,000,这与 80% 的患者能在建议的 6 周时间内接受 DMARD 治疗有关。
{"title":"Time to start disease modifying drugs for adults with seropositive rheumatoid arthritis: results of the first year of the national New Zealand Rheumatology Association (NZRA) audit.","authors":"William J Taylor, Nicola Dalbeth, Tracey Kain, Douglas White, Rebecca Grainger, Vicky Quincey","doi":"10.26635/6965.6414","DOIUrl":"https://doi.org/10.26635/6965.6414","url":null,"abstract":"<p><strong>Aim: </strong>This audit describes variation in the time from referral to starting disease modifying drug (DMARD) for people with newly diagnosed seropositive rheumatoid arthritis (RA), how frequently this was within the recommended 6 weeks and whether regional, service-level or patient-level factors were associated with this variation.</p><p><strong>Method: </strong>Rheumatologists submitted data on new patients with a new diagnosis of rheumatoid factor and/or cyclic-citrullinated peptide antibody positive RA. The association between visit funding, ethnicity, socio-economic deprivation, rurality, local specialist staffing levels and the time to DMARD treatment was assessed using Cox proportional-hazard models.</p><p><strong>Results: </strong>Data were collected on 355 patients over 12 months. Overall, 64.8% of patients commenced DMARD treatment within 6 weeks of referral and this was associated with rheumatologist FTE per 100,000 population (adjusted HR 2.47, 95%CI 1.27-4.81; p=0.008) and the rurality (Geographic Classification of Health [GCH]) of the patient (for R2 compared to U1 adjusted HR 0.20, 95%CI 0.09-0.43; p<0.001). There was no association between time to DMARD and ethnicity or socio-economic deprivation.</p><p><strong>Conclusion: </strong>There was significant variation in time to DMARD treatment, mainly related to variation in rheumatologist staffing levels and patient rurality. Rheumatologist staffing levels of 1.0 FTE/100,000 population was associated with 80% of patients meeting the recommended 6-week time to DMARD treatment.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1600","pages":"21-30"},"PeriodicalIF":1.2,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Midwifery experiences in rural Southern Aotearoa New Zealand: insights into pre-eclampsia management. 新西兰奥特亚罗瓦南部农村地区的助产经验:对子痫前期管理的见解。
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-02 DOI: 10.26635/6965.6458
Judith Sligo, Julia Corfe-Tan, Zoe Cotter, Jimmy Senara Eteuati, Hannah-Rose Hart, Rachael McConnell

Aim: This study investigated the experiences of rural midwives in the Southern region of Aotearoa New Zealand, focussing on practices and challenges in caring for pregnant individuals displaying signs of pre-eclampsia (PE).

Method: Conducted as part of the University of Otago's Trainee Intern Healthcare Evaluation Project, investigating the efficacy of the soluble FMS-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio test, this exploratory study employed qualitative research methods. Twenty-three midwives from nine locations across the Southern region were interviewed by trainee intern doctors (TIs) using a semi-structured interview protocol. Thematic analysis was applied to the data.

Results: The study highlighted the challenging context of rural midwifery, emphasising diverse working conditions, geographic complexities and the impact of the midwifery shortage. Midwives' decision making about PE depended on location, experience, scientific evidence, holistic model of care and the constant concern about PE. A model illustrating midwifery decision making in PE management was developed.

Conclusion: Rural midwives in Aotearoa New Zealand's Southern region managing PE cases face complex challenges. The model derived from this study illustrates the delicate balance that rural midwives navigate, emphasising the need for strategies to support their practice and preserve Aotearoa New Zealand's distinctive maternity care model.

目的:本研究调查了新西兰奥特亚罗瓦南部地区农村助产士的经验,重点是护理出现先兆子痫(PE)症状的孕妇的做法和挑战:这项探索性研究是奥塔哥大学实习生医疗保健评估项目的一部分,旨在调查可溶性FMS样酪氨酸激酶1(sFlt-1)/胎盘生长因子(PlGF)比率测试的有效性,研究采用了定性研究方法。来自南部地区九个地方的 23 名助产士接受了实习医生(TI)的半结构化访谈。对数据进行了主题分析:研究突出了农村助产工作的挑战性,强调了不同的工作条件、复杂的地理环境和助产士短缺的影响。助产士对 PE 的决策取决于地点、经验、科学证据、整体护理模式以及对 PE 的持续关注。我们建立了一个模型,说明助产士在 PE 管理方面的决策:新西兰奥特亚罗瓦南部地区的农村助产士在处理 PE 病例时面临着复杂的挑战。本研究得出的模型说明了农村助产士在处理 PE 病例时所面临的微妙平衡,强调需要制定策略来支持她们的实践,并维护新西兰奥特亚罗瓦独特的孕产妇护理模式。
{"title":"Midwifery experiences in rural Southern Aotearoa New Zealand: insights into pre-eclampsia management.","authors":"Judith Sligo, Julia Corfe-Tan, Zoe Cotter, Jimmy Senara Eteuati, Hannah-Rose Hart, Rachael McConnell","doi":"10.26635/6965.6458","DOIUrl":"https://doi.org/10.26635/6965.6458","url":null,"abstract":"<p><strong>Aim: </strong>This study investigated the experiences of rural midwives in the Southern region of Aotearoa New Zealand, focussing on practices and challenges in caring for pregnant individuals displaying signs of pre-eclampsia (PE).</p><p><strong>Method: </strong>Conducted as part of the University of Otago's Trainee Intern Healthcare Evaluation Project, investigating the efficacy of the soluble FMS-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio test, this exploratory study employed qualitative research methods. Twenty-three midwives from nine locations across the Southern region were interviewed by trainee intern doctors (TIs) using a semi-structured interview protocol. Thematic analysis was applied to the data.</p><p><strong>Results: </strong>The study highlighted the challenging context of rural midwifery, emphasising diverse working conditions, geographic complexities and the impact of the midwifery shortage. Midwives' decision making about PE depended on location, experience, scientific evidence, holistic model of care and the constant concern about PE. A model illustrating midwifery decision making in PE management was developed.</p><p><strong>Conclusion: </strong>Rural midwives in Aotearoa New Zealand's Southern region managing PE cases face complex challenges. The model derived from this study illustrates the delicate balance that rural midwives navigate, emphasising the need for strategies to support their practice and preserve Aotearoa New Zealand's distinctive maternity care model.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1600","pages":"52-61"},"PeriodicalIF":1.2,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Provision of care for diabetic retinopathy in New Zealand: are there ethnic disparities? 新西兰提供的糖尿病视网膜病变治疗:是否存在种族差异?
IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-02 DOI: 10.26635/6965.6282
Jahnvee Solanki, Tiwini Hemi, Amy Chen, Sarah Welch, Rachael Niederer

Aims: Ethnic disparities have been observed in treatment at first specialist appointments across various specialties within New Zealand. This study aimed to examine documentation and treatment decisions for diabetic retinopathy by ethnicity.

Methods: Retrospective audit of first specialist diabetic retinopathy clinic appointments for 388 patients at the Department of Ophthalmology, Te Whatu Ora Te Toka Tumai Auckland. Multiple domains of care were assessed, including comprehensiveness of history taking, examination, investigations and treatment decisions.

Results: Europeans comprised 42%, Māori only 9.5%, Pacific peoples 13.19%, Asian 32.7% and Middle Eastern/Latin American/African in 2%. Māori patients were eligible for a significantly greater number of treatments (p=0.001). The comprehensiveness of history taking (p=0.809), examination (p=0.513), investigations (p=0.623) and proportion of eligible treatments provided (p=0.788) was similar but did not reach the gold standard of care across all ethnicities.

Conclusions: The standard of care provided in first specialist appointments for diabetic retinopathy appear to be similar across all ethnic groups, although Māori were underrepresented and had a higher disease burden at presentation. Our data highlights the need to reduce barriers faced by Māori in accessing GP, optometry and retinopathy screening referrals in Auckland, and improving local consultation and treatment guidelines.

目的:在新西兰各专科的首次专科就诊治疗中发现了种族差异。本研究旨在按种族检查糖尿病视网膜病变的记录和治疗决定:方法:对奥克兰Te Whatu Ora Te Toka Tumai眼科部388名患者的首次糖尿病视网膜病变专科门诊预约进行回顾性审计。对多个护理领域进行了评估,包括病史采集、检查、检验和治疗决定的全面性:结果:欧洲人占 42%,毛利人仅占 9.5%,太平洋岛屿族裔占 13.19%,亚洲人占 32.7%,中东/拉丁美洲/非洲人占 2%。毛利患者接受治疗的次数明显较多(P=0.001)。所有种族的病史采集(p=0.809)、检查(p=0.513)、检验(p=0.623)和合格治疗比例(p=0.788)的全面性相似,但未达到黄金护理标准:结论:尽管毛利人在糖尿病视网膜病变首次专科就诊中的比例较低,且就诊时的疾病负担较重,但各族裔群体在首次专科就诊中提供的护理标准似乎相似。我们的数据突出表明,有必要减少奥克兰毛利人在获得全科医生、验光师和视网膜病变筛查转诊方面所面临的障碍,并改进当地的咨询和治疗指南。
{"title":"Provision of care for diabetic retinopathy in New Zealand: are there ethnic disparities?","authors":"Jahnvee Solanki, Tiwini Hemi, Amy Chen, Sarah Welch, Rachael Niederer","doi":"10.26635/6965.6282","DOIUrl":"10.26635/6965.6282","url":null,"abstract":"<p><strong>Aims: </strong>Ethnic disparities have been observed in treatment at first specialist appointments across various specialties within New Zealand. This study aimed to examine documentation and treatment decisions for diabetic retinopathy by ethnicity.</p><p><strong>Methods: </strong>Retrospective audit of first specialist diabetic retinopathy clinic appointments for 388 patients at the Department of Ophthalmology, Te Whatu Ora Te Toka Tumai Auckland. Multiple domains of care were assessed, including comprehensiveness of history taking, examination, investigations and treatment decisions.</p><p><strong>Results: </strong>Europeans comprised 42%, Māori only 9.5%, Pacific peoples 13.19%, Asian 32.7% and Middle Eastern/Latin American/African in 2%. Māori patients were eligible for a significantly greater number of treatments (p=0.001). The comprehensiveness of history taking (p=0.809), examination (p=0.513), investigations (p=0.623) and proportion of eligible treatments provided (p=0.788) was similar but did not reach the gold standard of care across all ethnicities.</p><p><strong>Conclusions: </strong>The standard of care provided in first specialist appointments for diabetic retinopathy appear to be similar across all ethnic groups, although Māori were underrepresented and had a higher disease burden at presentation. Our data highlights the need to reduce barriers faced by Māori in accessing GP, optometry and retinopathy screening referrals in Auckland, and improving local consultation and treatment guidelines.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1600","pages":"12-20"},"PeriodicalIF":1.2,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
NEW ZEALAND MEDICAL JOURNAL
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1